World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
115
Citations
47505
World Ranking
4558
National Ranking
174

Ton J. Rabelink publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ton J. Rabelink sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 659 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ton J. Rabelink D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ton J. Rabelink sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 115 D-Index — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Ton J. Rabelink is affiliated with Leiden University Medical Center in the Netherlands. Their research primarily focuses on fields related to medicine and biochemistry, genetics, and molecular biology, with a significant emphasis on molecular biology and nephrology.

The main topics of their work include:

  • Renal and related cancers
  • Vasculitis and related conditions
  • Chronic Kidney Disease and Diabetes
  • Systemic Lupus Erythematosus Research
  • Tissue Engineering and Regenerative Medicine
  • Renal Diseases and Glomerulopathies
  • Pluripotent Stem Cells Research

Rabelink has published extensively in several frequent venues, including:

  • Journal of the American Society of Nephrology
  • Nephrology Dialysis Transplantation
  • Kidney International Reports
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Reviews Nephrology

Recent publications demonstrate involvement in studying kidney metabolism, renal cell specialization, and artificial intelligence applications in nephrology. Selected papers include:

  • "Analyzing cell-type-specific dynamics of metabolism in kidney repair" (2022, Nature Metabolism)
  • "Phenotypic diversity and metabolic specialization of renal endothelial cells" (2021, Nature Reviews Nephrology)
  • "Spatial dynamic metabolomics identifies metabolic cell fate trajectories in human kidney differentiation" (2022, Cell Stem Cell)
  • "Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy" (2020, Kidney International)
  • "Oxidative Stress Leads to β-Cell Dysfunction Through Loss of β-Cell Identity" (2021, Frontiers in Immunology)

They frequently collaborate with a core group of coauthors, including:

  • Y K Onno Teng
  • Bernard M. van den Berg
  • Cees van Kooten
  • Gangqi Wang
  • Cathelijne W. van den Berg

Ton J. Rabelink's subfields of study span molecular biology, nephrology, pulmonary and respiratory medicine, surgery, and rheumatology. Their scholarly output reflects interdisciplinary engagement in these areas related to kidney function, cellular metabolism, and disease mechanisms, supporting ongoing research developments in renal medicine and associated biomedical fields.

Best Publications

  • Endothelial Function and Dysfunction Testing and Clinical Relevance

    John E. Deanfield;Julian P. Halcox;Ton J. Rabelink

  • Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

    Hermann Haller;Sadayoshi Ito;Joseph L. Izzo;Andrzej Januszewicz

  • Endothelial Progenitor Cell Dysfunction: A Novel Concept in the Pathogenesis of Vascular Complications of Type 1 Diabetes

    Cindy J.M. Loomans;Eelco J.P. de Koning;Frank J.T. Staal;Maarten B. Rookmaaker

  • Tetrahydrobiopterin restores endothelial function in hypercholesterolemia.

    E Stroes;J Kastelein;F Cosentino;W Erkelens

  • Stent Placement in Patients With Atherosclerotic Renal Artery Stenosis and Impaired Renal Function: A Randomized Trial

    Liesbeth Bax;Arend-Jan J. Woittiez;Hans J. Kouwenberg;Willem P. T. M. Mali

  • Expression of connective tissue growth factor in human renal fibrosis

    Yasuhiko Ito;Jan Aten;Richard J. Bende;Barry S. Oemar

  • Cellular regulation of endothelial nitric oxide synthase.

    Roland Govers;Ton J. Rabelink

  • Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication.

    E.S.G. Stroes;H.A. Koomans;T.J. Rabelink;T.W.A. de Bruin

  • Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy

    Anna Rita Cantelmo;Lena Christin Conradi;Aleksandra Brajic;Jermaine Goveia

  • Endothelin-A Receptor Antagonist–Mediated Vasodilatation Is Attenuated by Inhibition of Nitric Oxide Synthesis and by Endothelin-B Receptor Blockade

    Marianne C. Verhaar;Fiona E. Strachan;David E. Newby;Nicholas L. Cruden

  • The relevance of tissue angiotensin-converting enzyme: Manifestations in mechanistic and endpoint data

    Victor J. Dzau;Kenneth Bernstein;David Celermajer;Jerome Cohen;Jerome Cohen

  • Metabolic and Additional Vascular Effects of Thiazolidinediones

    Fabrice M. A. C Martens;Frank L. J. Visseren;Jacinthe Lemay;Eelco J. P. de Koning

  • 5-Methyltetrahydrofolate, the Active Form of Folic Acid, Restores Endothelial Function in Familial Hypercholesterolemia

    M. C. Verhaar;R. M. F. Wever;J. J. P. Kastelein;T. Van Dam

  • Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilation.

    Michel L Hijmering;Erik S.G Stroes;Jobien Olijhoek;Barbara A Hutten

  • Atherosclerosis and the two faces of endothelial nitric oxide synthase

    Robert M. F. Wever;Thomas F. Lüscher;Francesco Cosentino;Ton J. Rabelink

  • Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase.

    R. M. F. Wever;T. Van Dam;H. J. M. Van Rijn;F. De Groot

  • Folic acid reverts dysfunction of endothelial nitric oxide synthase

    E. S. G. Stroes;E. E. van Faassen;M. Yo;P. Martasek

  • The Metabolic Syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm

    Jobien K. Olijhoek;Yolanda van der Graaf;Jan-Dirk Banga;Ale Algra

  • Autologous Bone Marrow-Derived Mesenchymal Stromal Cells for the Treatment of Allograft Rejection After Renal Transplantation: Results of a Phase I Study

    Marlies E.J. Reinders;Johan W. de Fijter;Helene Roelofs;Ingeborg M. Bajema

  • Folates and Cardiovascular Disease

    M.C. Verhaar;E. Stroes;T.J. Rabelink

Frequent Co-Authors

Cees van Kooten
Cees van Kooten Leiden University Medical Center
J. Wouter Jukema
J. Wouter Jukema Leiden University Medical Center
Johan van der Vlag
Johan van der Vlag Radboud University
Martin J. Schalij
Martin J. Schalij Leiden University Medical Center
Jeroen J. Bax
Jeroen J. Bax Leiden University Medical Center
Menno V. Huisman
Menno V. Huisman Leiden University Medical Center
Erik S.G. Stroes
Erik S.G. Stroes University of Amsterdam
Friedo W. Dekker
Friedo W. Dekker Leiden University Medical Center
Alberto M. Pereira
Alberto M. Pereira University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are considering a medical career in the USA, online nursing degrees and alternative pathways can offer accessible and flexible options. For aspiring nurses, finding programs that fit your schedule and budget is key. Some of the cheapest rn to bsn online options allow you to further your education while balancing work and family commitments.

Are you already a nurse planning to advance your career? Accredited doctorate in nursing education online programs provide flexible routes to higher-level roles in education, leadership, and research. For those changing careers, msn direct entry programs online cater to non-nurses, helping you transition quickly into the nursing profession.

Admission requirements vary. Some easy nursing programs to get into provide more accessible entry points if you do not meet competitive criteria. Whatever path you choose, these online degrees can be valuable stepping stones towards your medical or healthcare career in the USA.

Best Scientists Citing Ton J. Rabelink

Trending Scientists

Recently Published Articles